VERU INC. Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31)
VERU INC. (VERU) had Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) of 5.00% as of 2012-09-30, per its 10-K filed 2012-12-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNetPercentage · last filed 2012-12-04
- 2012-09-30: Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) 5.00%.
| Period end | Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) |
|---|---|
| 2012-09-30 | 5.00% 10-K · filed 2012-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |